Table 1.
Demographic, clinical and cognitive characteristics, Mean (SD) of PD participants.
| Measure | PD (n=199) Mean (SD) | |
|---|---|---|
| Demographics | Age (years) | 67.7(8.2) |
| Gender (M/F) | 126/73 | |
| Years of Education | 16.4 (2.3) | |
| MDS-UPDRS III | 25.0 (13.0) | |
| H & Y | 2.1 (0.5) | |
| LEDD (mg/day) | 654.4 (465.9) | |
| Disease Duration (years) | 8.6 (5.4) | |
| Cognitive Status | NCI (101) / MCI+ (74) / PDD (24) | |
| Global Cognition | MoCA | 25.0 (4.0) |
| Attention | Letter Number Sequencing | 9.53 (2.54) |
| Trail Making A | 37.0 (20.3) | |
| Stroop Reading | 84.6 (16.6) | |
| Executive Function | Semantic Fluency | 19.0 (6.0) |
| Trail Making B-A | 58.4 (46.7) | |
| Stroop Interference | 34.5 (10.2) | |
| Phonemic Fluency | 15.0 (5.0) | |
| Memory | HVLT-R Immediate | 23.6 (6.0) |
| HVLT-R Delayed | 8.08 (3.17) | |
| Logical Memory I | 12.5 (4.2) | |
| Logical Memory II | 11.5 (4.5) | |
| Language | Boston Naming Test | 28.6 (1.7) |
| Visuospatial | Judgement of Line Orientation | 12.0 (2.0) |
[Abbreviations: MDS-UPDRS (Movement Disorders Society Unified Parkinson’s disease rating scale), H & Y (Modified Hoehn & Yahr), LEDD (Levodopa Equivalent Daily Dose), NCI (no cognitive impairment), MCI (mild cognitive impairment), PDD (Parkinson’s disease dementia), MoCA (Montreal Cognitive Assessment), HVLT-R (Hopkins Verbal Learning Test-Revised)]